Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Transfection and Structural Properties of Phytanyl Substituted Gemini Surfactant-Based Vectors for Gene Delivery Publisher Pubmed



Wang H1, 2 ; Kaur T3 ; Tavakoli N4 ; Joseph J1 ; Wettig S1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Pharmacy, University of Waterloo, Ontario, Kitchener, ON, 10 Victoria Str. S., Canada
  2. 2. Waterloo Institute for Nanotechnology, University of Waterloo, ON, Canada
  3. 3. Department of Biophysics, Panjab University, Chandigarh, India
  4. 4. School of Pharmacy, Isfahan University of Medical Sciences, Iran

Source: Physical Chemistry Chemical Physics Published:2013


Abstract

In this study, the transfection ability and cytotoxicity of a series of phytanyl substituted gemini surfactants, rationally designed and synthesized in an attempt to create cationic surfactants that will improve transfection efficiencies of non-viral vectors was evaluated in OVCAR-3 cells at the charge ratios (N+/P-) of 2:1, 5:1, and 10:1. Particle sizes, zeta potentials, and small angle X-ray scattering (SAXS) profiles were also determined. For each gemini surfactant complex, the transfection efficiency and cytotoxicity are observed to go through a more or less well-evidenced maximum, occurring at different values of the charge ratio (N+/P-), depending on the surfactant structure. Considering both results of in vitro transfection efficiency and cytotoxicity, the optimal charge ratio to formulate the complexes containing phy-3-m was found to be 5:1. The particle size decreased, while zeta potential increased with increasing N+/P -. Comparing particle size and zeta potential with transfection efficiency, no correlation between size/zeta potential and transfection ability was observed. Analysis of SAXS profiles indicates that the ability of phy-3-m delivery system to adopt multiple phases correlated well with their higher transfection efficiency in OVCAR-3 cells. © 2013 the Owner Societies.